All News #Library
Enforcement Report - Week of February 7, 2024
07 Feb 2024 //
FDA
Enforcement Report - Week of February 9, 2022
09 Feb 2022 //
FDA
Actavis Laboratories FL, Inc. Receives FDA Warning (Close Out) Letter
07 Sep 2021 //
FDA
Actavis Laboratories on Health Canada Inspection List
31 Dec 2019 //
HEALTH CANADA
Actavis Laboratories FL, Inc Receives FDA Warning Letter
06 Mar 2019 //
FDA
Actavis Laboratories, FL. Inc on Health Canada Inspection List
06 Mar 2019 //
HEALTH CANADA
Class 2 Medicines Recall: Actavis recall of batches of Irbesartan / HCTZ Tablets
03 Jan 2019 //
GOV UK
Valsartan products under recall - Updated November 27, 2018
28 Nov 2018 //
FDA
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
Enforcement Report - Week of August 1, 2018
01 Aug 2018 //
FDA
Enforcement Report - Week of March 7, 2018
07 Mar 2018 //
FDA
Enforcement Report - Week of November 1, 2017
01 Nov 2017 //
FDA
Enforcement Report - Week of October 4, 2017
04 Oct 2017 //
FDA
Enforcement Report - Week of September 13, 2017
13 Sep 2017 //
FDA
Enforcement Report - Week of July 19, 2017
19 Jul 2017 //
FDA
Teva Pharmaceuticals, USA Extends Voluntary Nationwide Recall
16 Jun 2017 //
FDA
Enforcement Report - Week of March 15, 2017
15 Mar 2017 //
FDA
Enforcement Report - Week of February 22, 2017
22 Feb 2017 //
FDA
US FDA Enforcement report- 13/Apr/2016
12 Apr 2016 //
FDA
Health Canada warns potential,allergic reactions to OTC topical products
17 Dec 2015 //
FDA
Actavis recalls Metformin HCl Tablets due to Out-of-Specification results
22 Oct 2015 //
FDA
Actavis High Blood Pressure Drug Fails to Win U.S. Approval
25 Dec 2014 //
BLOOMBERG

Market Place
Sourcing Support